Coronavirus vaccines are moving towards clinical trials, promises several biotech companies in the US

Just three months after the outbreak of the coronavirus pandemic, several biotech companies in the United States have ramped up their efforts to fight the disease with accelerated schedules for creating new vaccines and beginning clinical trials for potential treatments. In normal circumstances, vaccine development would take around 10 years. But the pharmaceutical industry is racing to compress this timeline with the support of non-profit organisations, government agencies and regulatory authorities. In just a few months, more than two dozen companies have announced promising vaccine programmes, speeding through the early stages of testing unlike ever before, The Strait Times reported.

Spotlight

Spotlight

Related News